FDA Inspection 1336134 — Hain-Celestial Canada, ULC

Hain-Celestial Canada, ULC — FEI 3000097071

The FDA completed an inspection of Hain-Celestial Canada, ULC on Sep 17, 2026 in Mississauga. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 3 citations were issued during this inspection. Product area: Drugs.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Sep 17, 2026
Fiscal Year
2026
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Mississauga (Canada)

Citations

IDCFRDescription
107921 CFR 211.22(a)Contract drug products--lack of responsibility
121321 CFR 211.67(a)Cleaning / Sanitizing / Maintenance
127421 CFR 211.68(a)Calibration/Inspection/Checking not done

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.